UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Management Meeting Reinforces Improving Outlook
Go back to UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Management Meeting Reinforces Improving Outlook| Johnson & Johnson (NYSE: JNJ) | Delayed: 272.46 +1.35 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.11 | 52 Week High | $126.07 | |||
| Open | $273.00 | 52 Week Low | $94.28 | |||
| Day High | $276.47 | P/E | 56.64 | |||
| Day Low | $270.56 | EPS | $4.81 | |||
| Volume | 3,073,851 | |||||
